ARS Pharmaceuticals, Inc.ARS Pharmaceuticals, Inc.ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.

No trades
See on Supercharts

SPRY fundamentals

ARS Pharmaceuticals, Inc. earnings per share and revenue

SPRY earnings per share for the last quarter are -0.20 USD whereas the estimation was -0.14 USD which accounts for -40.35% surprise. Company revenue for the same period amounts to 2.07 M USD despite the estimated figure of 575.00 k USD. Estimated earnings per share for the next quarter are -0.14 USD, and revenue is expected to reach 5.57 M USD. Also watch annual changes over time to get a bigger picture of SPRY earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise